The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Hyperglycemia as a Risk Factor for Cancer Progression
Open accessAbstract
As the prevalence of diabetes mellitus is substantially increasing worldwide, associated diseases such as renal failure, cardiovascular diseases, fatty liver, and cancers have also increased. A number of cancers such as pancreatic, liver, breast, and female reproductive cancers have shown an increased prevalence and a higher mortality rate in diabetic patients compared to healthy subjects. Thus, this suggests an association between diabetes, especially type 2 diabetes and cancer incidence and progression. Recent studies have suggested that hyperinsulinemia, chronic inflammation and hyperglycemia, all frequently seen in diabetics, may lead to increased tumor growth; the underlying molecular mechanisms of this association are not fully understood. In particular, chronic hyperglycemic episodes could serve as a direct or indirect mediator of the increase in tumor cell growth. Here, we will discuss our current understanding how hyperglycemia and cancer risk may be linked, and what the implications are for the treatment of diabetic cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680 · cited 1×
“The underlying mechanisms behind this association have not been fully elucidated; however, plausible connections consist of hyperinsulinemia, insulin resistance, chronic inflammation, oxidative stress, and hyperglycemia; all of these factors potentially promote tumor progression in various ways [6-10].”
BackgroundWhy Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,205
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 1×
“This leads to the increased expression of genes associated with glucose metabolism, angiogenesis and survival/antiapoptotic processes [30,31].”
BackgroundMetformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,349
Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions
Lee, J.-W., Bae, S.-H., Jeong, J.-W., Kim, S.-H., & Kim, K.-W. (2004) · Experimental & Molecular Medicine · doi:10.1038/emm.2004.1 · Cited by 1,117
Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115
Oral Antidiabetic Agents: Current Role in Type 2 Diabetes Mellitus
Krentz, A. J., & Bailey, C. J. (2005) · Drugs · doi:10.2165/00003495-200565030-00005 · Cited by 1,108
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
Giovannucci, E. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3109s · Cited by 959
Thomas, N., K, S., & Kapoor, N. (2016) · A Practical Guide to Diabetes Mellitus · doi:10.5005/jp/books/12651_7 · Cited by 943
Terminal Differentiation of Human Breast Cancer through PPARγ
Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., & Spiegelman, B. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80047-7 · Cited by 851
Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T. W. M., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.022 · Cited by 804
Epithelial-mesenchymal transition in cancer development and its clinical significance
Iwatsuki, M., Mimori, K., Yokobori, T., Ishi, H., Beppu, T., Nakamori, S., Baba, H., & Mori, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01419.x · Cited by 780
Apoptosis and cancer: the genesis of a research field
Cotter, T. G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2663 · Cited by 758
The Regulation of Hepatic Glutathione
Kaplowitz, N., Aw, T. Y., & Ookhtens, M. (1985) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.25.040185.003435 · Cited by 661
Zinc homeostasis and signaling in health and diseases: Zinc signaling
Fukada, T., Yamasaki, S., Nishida, K., Murakami, M., & Hirano, T. (2011) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-011-0797-4 · Cited by 597
Walters, S., Maringe, C., Coleman, M. P., Peake, M. D., Butler, J., Young, N., Bergström, S., Hanna, L., Jakobsen, E., Kölbeck, K., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202297 · Cited by 575
Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E. K., Calkin, A. C., Brownlee, M., Cooper, M. E., & El-Osta, A. (2009) · Diabetes · doi:10.2337/db08-1666 · Cited by 534
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2010) · Diabetes Care · doi:10.2337/dc09-1791 · Cited by 466
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Franciosi, M., Lucisano, G., Lapice, E., Strippoli, G. F. M., Pellegrini, F., & Nicolucci, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071583 · Cited by 428
Vaughn, A. E., & Deshmukh, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1807 · Cited by 408
PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer
Murphy, G. J., & Holder, J. C. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01559-5 · Cited by 386
Schmitt, M., Harbeck, N., Thomssen, C., et al. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657541 · Cited by 386
Hyperglycemia Regulates Hypoxia-Inducible Factor-1α Protein Stability and Function
Catrina, S.-B., Okamoto, K., Pereira, T., Brismar, K., & Poellinger, L. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3226 · Cited by 384
Insulin resistance and breast‐cancer risk
Bruning, P. F., Bonfrèr, J. M. G., van Noord, P. A. H., Hart, A. A. M., de Jong‐Bakker, M., & Nooijen, W. J. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520402 · Cited by 361
Diabetes mellitus and risk of prostate cancer: a meta-analysis
Bonovas, S., Filioussi, K., & Tsantes, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1415-6 · Cited by 327
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Soranna, D., Scotti, L., Zambon, A., Bosetti, C., Grassi, G., Catapano, A., La Vecchia, C., Mancia, G., & Corrao, G. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0462 · Cited by 274
Ways, D. K., Kukoly, C. A., deVente, J., Hooker, J. L., Bryant, W. O., Posekany, K. J., Fletcher, D. J., Cook, P. P., & Parker, P. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117872 · Cited by 266
on behalf of the Diabetes and Cancer Research Consortium, Johnson, J. A., Carstensen, B., Witte, D., Bowker, S. L., Lipscombe, L., & Renehan, A. G. (2012) · Diabetologia · doi:10.1007/s00125-012-2525-1 · Cited by 260
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
Blandino, G., Valerio, M., Cioce, M., Mori, F., Casadei, L., Pulito, C., Sacconi, A., Biagioni, F., Cortese, G., Galanti, S., et al. (2012) · Nature Communications · doi:10.1038/ncomms1859 · Cited by 242
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven, G. M. (2005) · PubMed · Cited by 239
Hyperglycemia, a Neglected Factor during Cancer Progression
Duan, W., Shen, X., Lei, J., Xu, Q., Yu, Y., Li, R., Wu, E., & Ma, Q. (2014) · BioMed Research International · doi:10.1155/2014/461917 · Cited by 236
Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma
Derr, R. L., Ye, X., Islas, M. U., Desideri, S., Saudek, C. D., & Grossman, S. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1098 · Cited by 225
Okumura, M., Yamamoto, M., Sakuma, H., Kojima, T., Maruyama, T., Jamali, M., Cooper, D. R., & Yasuda, K. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00276-8 · Cited by 206
Diabetes, cancer, and metformin: connections of metabolism and cell proliferation
Gallagher, E. J., & LeRoith, D. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06285.x · Cited by 202
Masur, K., Vetter, C., Hinz, A., Tomas, N. M., Henrich, H., Niggemann, B., & Zänker, K. S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606050 · Cited by 166
Han, L., Ma, Q., Li, J., Liu, H., Li, W., Ma, G., Xu, Q., Zhou, S., & Wu, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027074 · Cited by 162
Mitochondrial ROS – radical detoxification, mediated by protein kinase D
Störz, P. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.11.003 · Cited by 151
Takahashi, A., Kimura, F., Yamanaka, A., Takebayashi, A., Kita, N., Takahashi, K., & Murakami, T. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-53 · Cited by 141
Diabetes and cancer I: risk, survival, and implications for screening
Onitilo, A. A., Engel, J. M., Glurich, I., Stankowski, R. V., Williams, G. M., & Doi, S. A. R. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9972-3 · Cited by 131
Diabetes and Cancer: Is Diabetes Causally Related to Cancer?
Suh, S., & Kim, K. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.3.193 · Cited by 122
Glycemic memory associated epigenetic changes
Siebel, A. L., Fernández, A. Z., & El‐Osta, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.005 · Cited by 102
Zordoky, B. N. M., Bark, D., Soltys, C. L., Sung, M. M., & Dyck, J. R. B. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.01.023 · Cited by 98
Long-term effects of insulin glargine on the risk of breast cancer
Suissa, S., Azoulay, L., Dell’Aniello, S., Evans, M., Vora, J. P., & Pollak, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2190-9 · Cited by 97
Cancer incidence among patients treated with antidiabetic pharmacotherapy
Oliveria, S. A., Koro, C. E., Yood, M. U., & Sowell, M. O. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2007.11.002 · Cited by 89
Takatani‐Nakase, T., Matsui, C., Maeda, S., Kawahara, S., & Takahashi, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090136 · Cited by 82
Does Insulin Glargine Increase the Risk of Cancer Compared With Other Basal Insulins?
Fagot, J., Blotière, P., Ricordeau, P., Weill, A., Alla, F., & Allemand, H. (2012) · Diabetes Care · doi:10.2337/dc12-0506 · Cited by 80
Controlling Hyperglycemia as an Adjunct to Cancer Therapy
Krone, C. A., & Ely, J. T. A. (2005) · Integrative Cancer Therapies · doi:10.1177/1534735404274167 · Cited by 76
Ma (2011) · Oncology Reports · doi:10.3892/or.2011.1150 · Cited by 71
Metformin as an antitumor agent in cancer prevention and treatment
Li, D. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00119.x · Cited by 70
Liu, H., Ma, Q., & Li, J. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0617-0 · Cited by 68
Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells
López, V., & Kelleher, S. L. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.10.011 · Cited by 67
Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy
Hosokawa, T., Kurosaki, M., Tsuchiya, K., Matsuda, S., Muraoka, M., Suzuki, Y., Tamaki, N., Yasui, Y., Nakata, T., Nishimura, T., et al. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i2.249 · Cited by 57
Roles for neuregulins in human cancer
Stove, C. P., & Bracke, M. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-6917-6 · Cited by 54
Epigenetic mechanisms of hyperglycemic memory
Cencioni, C., Spallotta, F., Greco, S., Martelli, F., Zeiher, A. M., & Gaetano, C. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.04.014 · Cited by 54
Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes
Johnson, J. A., & Pollak, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1855-0 · Cited by 48
Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer
Park, J., Sarode, V. R., Euhus, D., Kittler, R., & Scherer, P. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214400109 · Cited by 44
Self-citationHahn, T., Barth, S., Hofmann, W. E., Reich, O., Lang, I., & Desoyé, G. (1998) · International Journal of Cancer · Cited by 44
Cited by
Obesity, Inflammation, and Cancer
Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A., & Hsueh, W. A. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044359 · Cited by 794
Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
Onstad, M. A., Schmandt, R. E., & Lu, K. H. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.4638 · Cited by 643
Challenges and Perspectives in the Treatment of Diabetes Associated Breast Cancer
Samuel, S. M., Varghese, E., Varghese, S., & Büsselberg, D. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.08.004 · Cited by 141
Bellahcène, A., Nokin, M.-J., Castronovo, V., & Schalkwijk, C. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.010 · Cited by 98
Rojas, A., Añazco, C., González, I., & Araya, P. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy012 · Cited by 82
Metadata
- Authors
- Ryu, T. Y., Park, J., & Scherer, P. E.
- Venue
- Diabetes & Metabolism Journal
- Publisher
- Korean Diabetes Association
- Published
- 2014
- Volume
- 38
- Issue
- 5
- Pages
- 330
- ISSN
- 2233-6079 (ISSN-L)
- 2233-6087
- OpenAlex
- W2138121862
- Cited by
- 331
- References
- 62
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.